Home  >  Products  >  AKR1B1 (aldo-keto reductase family 1, member B1 (aldose reductase)) Blocking Peptide (the N terminal of protein) (100ug)
AKR1B1 (aldo-keto reductase family 1, member B1 (aldose reductase)) Blocking Peptide (the N terminal of protein) (100ug)

AKR1B1 (aldo-keto reductase family 1, member B1 (aldose reductase)) Blocking Peptide (the N terminal of protein) (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-AKR1B1 antibody (Catalogue #: ARP48179_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP48179
Size: 100 ug
Weight: 36kDa
Gene: 231
Format: Lyophilized powder
Target: AKR1B1 is a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member catalyzes the reduction of a number of aldehydes, including the aldehyde form of glucose, and is thereby implicated in the development of diabetic complications by catalyzing the reduction of glucose to sorbitol. This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member catalyzes the reduction of a number of aldehydes, including the aldehyde form of glucose, and is thereby implicated in the development of diabetic complications by catalyzing the reduction of glucose to sorbitol. There are a few putative pseudogenes for this gene, and one of them has been confirmed and mapped to chromosome 3. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: ADR; ALDR1; ALR2; AR; MGC1804